Marilyn J. Lemmon

1.7k total citations
22 papers, 1.4k citations indexed

About

Marilyn J. Lemmon is a scholar working on Cancer Research, Biotechnology and Molecular Biology. According to data from OpenAlex, Marilyn J. Lemmon has authored 22 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Cancer Research, 9 papers in Biotechnology and 5 papers in Molecular Biology. Recurrent topics in Marilyn J. Lemmon's work include Cancer, Hypoxia, and Metabolism (10 papers), Cancer Research and Treatments (9 papers) and Virus-based gene therapy research (5 papers). Marilyn J. Lemmon is often cited by papers focused on Cancer, Hypoxia, and Metabolism (10 papers), Cancer Research and Treatments (9 papers) and Virus-based gene therapy research (5 papers). Marilyn J. Lemmon collaborates with scholars based in United States, United Kingdom and Italy. Marilyn J. Lemmon's co-authors include Elaine M. Zeman, Julia Brown, V.Kate Hirst, Jeremy Brown, William W. Lee, Jeffrey M. Brown, J. Martin Brown, Carla Heise, David H. Kirn and Michael R. Horsman and has published in prestigious journals such as Cancer Cell, International Journal of Radiation Oncology*Biology*Physics and Radiotherapy and Oncology.

In The Last Decade

Marilyn J. Lemmon

21 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Marilyn J. Lemmon United States	17	638	579	348	343	310	22	1.4k
J A Double United Kingdom	15	821 1.3×	374 0.6×	523 1.5×	70 0.2×	91 0.3×	29	1.7k
Carol Waghorne Canada	16	1.3k 2.1×	377 0.7×	528 1.5×	118 0.3×	165 0.5×	29	2.1k
Matilde Olivé United States	13	1.2k 1.9×	444 0.8×	978 2.8×	292 0.9×	94 0.3×	18	2.1k
Gillian Paine-Murrieta United States	16	1.4k 2.2×	545 0.9×	323 0.9×	95 0.3×	79 0.3×	18	2.1k
P.W. Sheldon United Kingdom	24	431 0.7×	551 1.0×	319 0.9×	74 0.2×	119 0.4×	53	1.5k
Elaine M. Zeman United States	16	364 0.6×	461 0.8×	124 0.4×	51 0.1×	134 0.4×	38	978
Sang Hie Kim United States	15	452 0.7×	116 0.2×	292 0.8×	307 0.9×	164 0.5×	24	885
Michael I. Walton United Kingdom	28	1.7k 2.7×	442 0.8×	719 2.1×	87 0.3×	88 0.3×	49	2.5k
Ulrike Sattler Germany	15	1.4k 2.1×	884 1.5×	350 1.0×	84 0.2×	71 0.2×	20	2.0k
David H. Kern United States	21	626 1.0×	249 0.4×	577 1.7×	96 0.3×	43 0.1×	76	1.5k

Countries citing papers authored by Marilyn J. Lemmon

Since Specialization

Citations

This map shows the geographic impact of Marilyn J. Lemmon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marilyn J. Lemmon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marilyn J. Lemmon more than expected).

Fields of papers citing papers by Marilyn J. Lemmon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marilyn J. Lemmon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marilyn J. Lemmon. The network helps show where Marilyn J. Lemmon may publish in the future.

Co-authorship network of co-authors of Marilyn J. Lemmon

This figure shows the co-authorship network connecting the top 25 collaborators of Marilyn J. Lemmon. A scholar is included among the top collaborators of Marilyn J. Lemmon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marilyn J. Lemmon. Marilyn J. Lemmon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pardo, Andrea C., Sonika Agarwal, Brigitte Vollmer, et al.. (2025). Fetal Callosal Anomalies: A Narrative Review and Practical Recommendations for Pediatric Neurologists. Pediatric Neurology. 165. 117–127.

Fox, Mary E., Marilyn J. Lemmon, Amato J. Giaccia, Nigel P. Minton, & J. Martin Brown. (2003). Genetically Modified Clostridium for Gene Therapy of Tumors. Humana Press eBooks. 35. 413–418. 2 indexed citations

Stubdal, Hilde, Marilyn J. Lemmon, Patricia J. Holman, et al.. (2003). A prodrug strategy using ONYX-015-based replicating adenoviruses to deliver rabbit carboxylesterase to tumor cells for conversion of CPT-11 to SN-38.. PubMed. 63(20). 6900–8. 27 indexed citations

Johnson, Leisa, Annie Shen, John Charles Kunich, et al.. (2002). Selectively replicating adenoviruses targeting deregulated E2F activity are potent, systemic antitumor agents. Cancer Cell. 1(4). 325–337. 150 indexed citations

Heise, Carla, Marilyn J. Lemmon, & David H. Kirn. (2000). Efficacy with a replication-selective adenovirus plus cisplatin-based chemotherapy: dependence on sequencing but not p53 functional status or route of administration.. PubMed. 6(12). 4908–14. 87 indexed citations

Kim, Il Han, Marilyn J. Lemmon, & Julia Brown. (1993). The Influence of Irradiation of the Tumor Bed on Tumor Hypoxia: Measurements by Radiation Response, Oxygen Electrodes, and Nitroimidazole Binding. Radiation Research. 135(3). 411–411. 34 indexed citations

Stone, Helen B., et al.. (1992). Pharmacological modification of tumor blood flow: Lack of correlation between alteration of mean arterial blood pressure and changes in tumor perfusion. International Journal of Radiation Oncology*Biology*Physics. 22(1). 79–86. 25 indexed citations

Minchinton, Andrew I., Marilyn J. Lemmon, Michaël Tracy, et al.. (1992). Second-generation 1,2,4-benzotriazine 1,4-di-N-oxide bioreductive anti-tumor agents: Pharmacology and activity in vitro and in vivo. International Journal of Radiation Oncology*Biology*Physics. 22(4). 701–705. 23 indexed citations

Lemmon, Marilyn J. & Julia Brown. (1991). Hydralazine does not increase hypoxia in tumors growing in preirradiated tissue. International Journal of Radiation Oncology*Biology*Physics. 21(6). 1435–1440. 6 indexed citations

10.

Lemmon, Marilyn J., et al.. (1991). SR 4233: A tumor specific radiosensitizer active in fractionated radiation regimes. Radiotherapy and Oncology. 20. 151–156. 41 indexed citations

11.

Brown, Jeremy, et al.. (1991). Structure–activity Relationships for Tumour Radiosensitization by Analogues of Nicotinamide and Benzamide. International Journal of Radiation Biology. 59(3). 739–748. 13 indexed citations

12.

Brown, Jeffrey M. & Marilyn J. Lemmon. (1991). Tumor hypoxia can be exploited to preferentially sensitize tumors to fractionated irradiation. International Journal of Radiation Oncology*Biology*Physics. 20(3). 457–461. 77 indexed citations

13.

Zeman, Elaine M., Marilyn J. Lemmon, & J. Martin Brown. (1990). Aerobic radiosensitization by sr 4233 in vitro and in vivo. International Journal of Radiation Oncology*Biology*Physics. 18(1). 125–132. 25 indexed citations

14.

Brown, Julia & Marilyn J. Lemmon. (1990). Potentiation by the hypoxic cytotoxin SR 4233 of cell killing produced by fractionated irradiation of mouse tumors.. PubMed. 50(24). 7745–9. 150 indexed citations

15.

Zeman, Elaine M., et al.. (1989). Structure-activity relationships for benzotriazine DI-N-oxides. International Journal of Radiation Oncology*Biology*Physics. 16(4). 977–981. 55 indexed citations

16.

Zeman, Elaine M., V.Kate Hirst, Marilyn J. Lemmon, & Jeremy Brown. (1988). Enhancement of radiation-induced tumor cell killing by the hypoxic cell toxin SR 4233. Radiotherapy and Oncology. 12(3). 209–218. 75 indexed citations

17.

Horsman, Michael R., J. Martin Brown, D. Phil, et al.. (1988). Mechanism of action of the selective tumor radiosensitizer nicotinamide. International Journal of Radiation Oncology*Biology*Physics. 15(3). 685–690. 65 indexed citations

18.

Horsman, Michael R., Dennis Brown, Marilyn J. Lemmon, J. Martin Brown, & William W. Lee. (1986). Preferential tumor radiosensitization by analogs of nicotinamide and benzamide. International Journal of Radiation Oncology*Biology*Physics. 12(8). 1307–1310. 43 indexed citations

19.

Zeman, Elaine M., Jeremy Brown, Marilyn J. Lemmon, V.Kate Hirst, & William W. Lee. (1986). SR-4233: A new bioreductive agent with high selective toxicity for hypoxic mammalian cells. International Journal of Radiation Oncology*Biology*Physics. 12(7). 1239–1242. 327 indexed citations

20.

Sharma, Ruchi, et al.. (1985). Sister-chromatid exchange and cell replication kinetics in fetal and maternal cells after treatment with chemical teratogens. Mutation Research/Genetic Toxicology. 158(3). 217–231. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact